@article {Mansouri2020.08.16.20175935, author = {David Mansouri and Stephen T McSorley and James H Park and Clare Orange and Paul G Horgan and Donald C McMillan and Joanne Edwards}, title = {THE INFLAMMATORY MICROENVIRONMENT IN SCREEN-DETECTED PREMALIGANT ADENOMATOUS POLYPS: EARLY RESULTS FROM THE INTEGRATED TECHNOLOGIES FOR IMPROVED POLYP SURVEILLANCE (INCISE) PROJECT}, elocation-id = {2020.08.16.20175935}, year = {2020}, doi = {10.1101/2020.08.16.20175935}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Introduction Around 40\% of patients who attend for colonoscopy following a positive stool screening test have adenomatous polyps. Identifying which patients have a higher propensity for malignant transformation is currently poorly understood. The aim of the present study was to assess whether the type and intensity of inflammatory infiltrate differs between high-grade (HGD) and low-grade dysplastic (LGD) screen detected adenomas.Methods A representative sample of 207 polyps from 134 individuals were included from a database of all patients with adenomas detected through the first round of the Scottish Bowel Screening Programme (SBoSP) in NHS GG\&C (April 2009 to April 2011).Inflammatory cell phenotype infiltrate was assessed by immunohistochemistry for CD3+, CD8+, CD45+ and CD68+ in a semi-quantitative manner at 20x resolution. Immune-cell infiltrate was graded as absent, weak, moderate or strong.Patient and polyp characteristics and inflammatory infiltrate were then compared between HGD and LGD polyps.Results CD3+ infiltrate was significantly higher in HGD polyps compared to LGD polyps (74\% vs 69\%, p\<0.05). CD8+ infiltrate was significantly higher in HGD polyps compared to LGD polyps (36\% vs 13\%, p\<0.001) where as CD45+ infiltrate was not significantly different(69\% vs 64\%, p=0.401). There was no significant difference in CD68+ infiltrate (p=0.540) or total inflammatory cell infiltrate (calculated from CD3+ and CD68+) (p=0.226).Conclusions This study reports an increase in CD3+ and CD8+ infiltrate with progression from LGD to HGD in colonic adenomas. It may therefore have a use in the prognostic stratification and treatment of dysplastic polyps.Competing Interest StatementThe authors have declared no competing interest.Funding StatementStudy funded by a research grant from charitable organisation The Cunningham Trust, SCO13499, Ref ACC/KWF/CT12/21.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for use of this tissue was obtained from the West of Scotland Research Ethics Committee (12/WS/0152 An investigation into tumour and host prognostic factors in early stage colorectal cancer and their correlation with clinical outcome. June 2012. Amendment approved December 2012).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccess to study data available on request.}, URL = {https://www.medrxiv.org/content/early/2020/08/17/2020.08.16.20175935}, eprint = {https://www.medrxiv.org/content/early/2020/08/17/2020.08.16.20175935.full.pdf}, journal = {medRxiv} }